Study finds potential target for stopping immune system attacks in autoimmune diseases

Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body’s immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies.

Metabolic syndrome linked to higher pancreatic cancer risk, study shows

Study finds a significant association between metabolic syndrome and an increased risk of pancreatic cancer, highlighting the importance of MetS prevention and management.

December 18, 2023

Sanofi says no supply interruptions after landing FDA warning letter for US site

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 22, 2025

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.